Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
US Army
US Department of Justice
Cantor Fitzgerald
Daiichi Sankyo
Queensland Health
Chinese Patent Office
Teva
Julphar

Generated: August 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207975

« Back to Dashboard

NDA 207975 describes VANTRELA ER, which is a drug marketed by Teva Branded Pharm and is included in one NDA. There are three patents protecting this drug. Additional details are available on the VANTRELA ER profile page.

The generic ingredient in VANTRELA ER is hydrocodone bitartrate. There are twenty-three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrocodone bitartrate profile page.
Summary for 207975
Tradename:VANTRELA ER
Applicant:Teva Branded Pharm
Ingredient:hydrocodone bitartrate
Patents:3
Formulation / Manufacturing:see details
Generic Entry Opportunity Date for 207975
Generic Entry Date for 207975*:
Constraining patent/regulatory exclusivity:
Dosage:
TABLET, EXTENDED RELEASE;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Medical Subject Heading (MeSH) Categories for 207975

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrength15MG
Approval Date:Jan 17, 2017TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Jul 31, 2029Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Sep 13, 2027Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Sep 13, 2027Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Julphar
Federal Trade Commission
Fish and Richardson
Boehringer Ingelheim
Cerilliant
Healthtrust
UBS
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.